Evidence map›Paper›PMID 42433370›Full record

ArticleFrontiers in immunology2026

Synergistic TCR-independent action of IL-33 and IL-12 drive a potent IFNγ secretory program in human circulating MAIT cells with immunomodulatory properties.

Carlota García-Escribano, Maria Gallardo-Jiménez, Ana García-Cadarso, Paloma Fernández Martínez, Ricardo Arroyo-Solera, Luis Senador Zaldívar-Martínez, Kelin Lin, Jeffrey Aubé, Patricia Barral, Tomás Chivato and 4 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Carlota García-EscribanoDepartamento de Ciencias Médicas Básicas, Facultad de Medicina, Instituto de Medicina Molecular Aplicada-Nemesio Díez (IMMA-ND), Universidad San Pablo-CEU, CEU Universities, Boadilla del Monte, Spain.
Maria Gallardo-JiménezDepartamento de Ciencias Médicas Básicas, Facultad de Medicina, Instituto de Medicina Molecular Aplicada-Nemesio Díez (IMMA-ND), Universidad San Pablo-CEU, CEU Universities, Boadilla del Monte, Spain.
Ana García-CadarsoDepartamento de Ciencias Médicas Básicas, Facultad de Medicina, Instituto de Medicina Molecular Aplicada-Nemesio Díez (IMMA-ND), Universidad San Pablo-CEU, CEU Universities, Boadilla del Monte, Spain.
Paloma Fernández MartínezDepartamento de Ciencias Médicas Básicas, Facultad de Medicina, Instituto de Medicina Molecular Aplicada-Nemesio Díez (IMMA-ND), Universidad San Pablo-CEU, CEU Universities, Boadilla del Monte, Spain.
Ricardo Arroyo-SoleraDepartamento de Ciencias Médicas Básicas, Facultad de Medicina, Instituto de Medicina Molecular Aplicada-Nemesio Díez (IMMA-ND), Universidad San Pablo-CEU, CEU Universities, Boadilla del Monte, Spain.
Luis Senador Zaldívar-MartínezDepartamento de Ciencias Médicas Básicas, Facultad de Medicina, Instituto de Medicina Molecular Aplicada-Nemesio Díez (IMMA-ND), Universidad San Pablo-CEU, CEU Universities, Boadilla del Monte, Spain.
Kelin LinDivision of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
Jeffrey AubéDivision of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
Patricia BarralThe Peter Gorer Department of Immunobiology, King's College London, London, United Kingdom.
Tomás ChivatoDepartamento de Ciencias Médicas Básicas, Facultad de Medicina, Instituto de Medicina Molecular Aplicada-Nemesio Díez (IMMA-ND), Universidad San Pablo-CEU, CEU Universities, Boadilla del Monte, Spain.
Domingo BarberDepartamento de Ciencias Médicas Básicas, Facultad de Medicina, Instituto de Medicina Molecular Aplicada-Nemesio Díez (IMMA-ND), Universidad San Pablo-CEU, CEU Universities, Boadilla del Monte, Spain.
Maria M EscribeseDepartamento de Ciencias Médicas Básicas, Facultad de Medicina, Instituto de Medicina Molecular Aplicada-Nemesio Díez (IMMA-ND), Universidad San Pablo-CEU, CEU Universities, Boadilla del Monte, Spain.
Elena IzquierdoDepartamento de Ciencias Médicas Básicas, Facultad de Medicina, Instituto de Medicina Molecular Aplicada-Nemesio Díez (IMMA-ND), Universidad San Pablo-CEU, CEU Universities, Boadilla del Monte, Spain.
Juan Carlos López-RodríguezDepartamento de Ciencias Médicas Básicas, Facultad de Medicina, Instituto de Medicina Molecular Aplicada-Nemesio Díez (IMMA-ND), Universidad San Pablo-CEU, CEU Universities, Boadilla del Monte, Spain.

Funding

cGMP Manufacture, Fill-Finish, Release, Analytical and Stability Testing and Stability Program of a Nanoparticle Based HIV Envelope Vaccine75N93022D00005 · NIAID · INTERNATIONAL AIDS VACCINE INITIATIVE · PI HASSELL, THOMAS · 2022 to 2025
$8.0M
Task Area A shall encompass annual follow-up of cohort members, clinical events investigations, study operations, and data analysis and manuscript writing. If implemented, Task A.1 will provide fundin75N92020D00005 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WATSON, KAROL E · 2020 to 2025
$5.1M
NHLBI NIH HHS 75N92020D00005NIAID NIH HHS 75N93022D00005NIDA NIH HHS 75N95020D00005NIH HHS 75N93023D00005NIH HHS 75N99020D00005
6 · The paper itself

Abstract

Introduction: Mucosal-Associated Invariant T (MAIT) cells are a subset of unconventional T cells that rapidly respond to early signs of inflammation, infection, and tissue damage. While MAIT cells have been typically associated with microbial infections, given their ability to respond to both microbial-derived riboflavin metabolites and proinflammatory cytokines such as IL-12, IL-15, or IL-18, their role in other inflammatory conditions remains mostly unknown. Alarmins, including IL-25, IL-33, and thymic stromal lymphopoietin (TSLP), are crucial effectors for early inflammatory responses, being released upon epithelial damage and strongly promoting the polarization of a wide variety of immune cells, including leukocytes like neutrophils, monocytes, macrophages, dendritic cells (DCs), NK cells, ILCs and T cells. However, how alarmins-induced environments influence MAIT cells' activity and function is yet to be explored. Methods: In this study, we investigate the roles of alarmins in controlling MAIT cell activation and function. Results: We found that IL-33, but not IL-25 or TSLP, combined with the TCR-independent stimuli IL-12p70 (but not 5-OP-RU), induces a potent IFNγ secretory/cytotoxic program on MAIT cells. This response was strongly dependent on p38 MAPK signaling and glycolytic metabolism. Beyond IFNγ, IL-33/IL-12p70-activated MAIT cells secrete a diverse panel of immune mediators, including TNF, VEGF, OSM, CXCL11, and CCL3. Notably, conditioned media from purified Vα7.2 Discussion: These findings reveal a broader immunomodulatory potential for MAIT cells to influence diverse immune compartments during inflammatory response.

Indexed as

Interferon-gammaInterleukin-12Interleukin-33Mucosal-Associated Invariant T CellsCells, CulturedCytokinesHumansImmunomodulationLymphocyte ActivationReceptors, Antigen, T-CellCytokinesIL33 protein, humanInterferon-gammaInterleukin-12Interleukin-33Receptors, Antigen, T-CellGlycolysisIFNγIL-12p70IL-33MAIT cellsmonocytesP38-MAPKsecretome

Identifiers

PMID42433370
PMCPMC13349841

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.